Anti-PD-1 (Nivolumab) Biotinylated Antibody

Anti-PD-1 (Nivolumab) Biotinylated Antibodyis available at Gentaur for Next week Delivery.

Description: Nivolumab, trade name Opdivo, is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with Iplimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with Iplimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma.

Immunogen Sequence:Human programmed cell death 1 receptor (PD1)

Target Alternative Name:/

Species Reactivities:Human

Tag Line:Mouse monoclonal antibody to detect biotinylated PD-1 in human samples

Formulation:In PBS, pH 7.2, 30% glycerol, 0.5% BSA, 0.5 mM EDTA and 0.03% proclin

Purification: Affinity purified

Application:ELISA

Positive Control:/

Application And Usages:ELISA 1 µg

Handling:The antibody solution should be gently mixed before use.